AANEM News Express

AANEM News Express

Submit Your Abstract for the Myasthenia Gravis Foundation of America’s 2021 Scientific Session

3/23/2021
 
MGFA-Large-Thumb_1.jpgDo you have research to share about myasthenia gravis or other disorders of the neuromuscular junction? If so, submit an abstract for the annual Scientific Session of the Myasthenia Gravis Foundation of America, Inc. (MGFA) by June 15, 2021. 
 
The MGFA Annual Scientific Session provides neurologists and others an informal opportunity to discuss their basic or clinical research work related to the neuromuscular junction. This year’s session will be held in conjunction with the AANEM 2021 Annual Meeting Aurora, Colorado at the Gaylord Rockies Resort & Convention Center on Wednesday, October 13 from 8:00am – noon. 
 
Abstract Details
  • Anyone is welcome to submit an abstract
  • Abstract authors do not need to be members of MGFA or sponsored by a member. 
  • The quality of the abstract will determine whether it is accepted. 
  • Abstract poster presentations are encouraged - they are generally works in progress.
  • Abstract submission deadline: June 15, 2021
  • Submit your abstract today
Please note: Abstracts will be submitted through the American Association of Neuromuscular & Electrodiagnostic Medicine’s website. If you do not already have a username and account at AANEM.org, you will need to create one to login and submit your abstract. 
 
Questions? Please email dlevin@myasthenia.org or call (800) 541-5454.
 
 


View Related News Stories:

  MeetingsEducation Abstract Annual Meeting


Recent AANEM News

Remembering George Kraft, MD, MS

The American Clinical Neurophysiology Society to Hold Another Townhall Meeting of Clinical Neurophysiology, Epilepsy, and Neuromuscular Fellowship Program Directors

Science News: Amyotrophic Lateral Sclerosis and Noninvasive Positive Pressure Ventilatory Support: "Nasal Noninvasive Ventilation" or "Noninvasive Ventilatory Support"?

CMS Finalizes Updates to Physician Fee Schedule

Advocacy in Action: State Liaison Leads the Way for Patient Advocacy in Washington and Beyond





Advertisement

ABEM

Advertisement

Donate

Advertisement